Skip to main content
Paradromics

Paradromics

ENABLING NEUROTECHNOLOGY Paradromics builds brain-computer interface (BCI) technologies for seamless human-technology integration, designed to restore and enhance human capabilities. By capturing brain activity at the resolution of individual neurons, our high-data-rate platform creates a foundation for the most advanced BCI applications. With each new application, we will create human capabilities that transcend disabilities, and eventually, biology itself. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI. Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics achieved its first human implantation of the Connexus BCI as part of the FDA-approved Connect-One study in June 2026, marking a major milestone toward delivering its first product to people living with severe motor impairment.www.paradromics.com

Search complete. 13 mentions across 5 episodes found for "Paradromics".

Sep 30, 2026

Ryan TanakaHOST
18:25
The link to apply is neuralink.com/careers.
Ryan TanakaHOST
18:29
First, Paradromics, the other brain computer interface company in Austin, put out this press release.
Ryan TanakaHOST
18:36
Their first patient is a 68-year-old woman in Michigan with a motor neuron disease that took her speech.
Ryan TanakaHOST
18:43
She was implanted in June at University of Michigan Health with their Connexis device, which has 421 electrodes, and in September, she generated her own sentences in real time, answered open-ended questions, and spoke with her grandchildren on a live phone call.
Ryan TanakaHOST
18:59
The first sentence she chose to say on her own was, "Okay, I have a lot to say." And when the neurosurgeon asked what she would tell someone considering the study, she said, "Don't be afraid.
Ryan TanakaHOST
19:11
It's a wonderful experience to help others by participation in research." Paradromics CEO Matt Angle shared, "She determines what she wants to say, and the system enables her to say it." Secondly, Science Corporation, the company founded by Neuralink's former president Max Hodak, posted this.
speaker_7SOUNDBITE_SPEAKER
19:34
I had perfect vision, uh, up till 2010.
speaker_7SOUNDBITE_SPEAKER
19:37
Then I was diagnosed with Stargardt.
Charlie FinkHOST
15:57
It's a company that makes a, um, a, a VR treadmill, which is something, of course, that we have talked about since the beginning of VR, or at least this stage of VR, in the, uh, early teens.
Charlie FinkHOST
16:12
There was, there is a company that I've never heard of, [clears throat] excuse me, Pandro- Paradromics, um, and they have a product called Connexix, which is a brain-computer interface that uses 400 electrodes to capture neural signals.
Charlie FinkHOST
16:28
They've got a woman who is, um, paralyzed and has been unable to speak for many years, and now it is able not only to s- help her speak, but also she can think and have it not pick that up, only her, it only picks up her intention to speak.
Charlie FinkHOST
16:45
There is a great video in my column.
Michael WearHOST
3:52
Also in the news, a brain implant has empowered a patient with a neurological disorder that has made it difficult for her to speak to be able to think her words, which the implant can translate in real time.
Michael WearHOST
4:06
The company, Paradromics, said the woman, a 68-year-old Michigander, has been able to have conversations using a computer-generated voice.
Michael WearHOST
4:15
She's also been able to share her thoughts on the phone, speaking to her grandkids.
Michael WearHOST
4:20
When asked if she had any advice for her grandchildren, she thought, and the electrode sensed, "Pray continuously." This system is wireless, meaning the patient doesn't have to be connected to a computer system via cords.
Lucy TassellHOST
3:12
[upbeat music] And today's good news: a woman in the US with a paralyzing neurological disorder has been given the ability to speak again, thanks to a wireless brain implant.
Lucy TassellHOST
3:24
The device, developed by American biotech firm Paradromics, allows the 68-year-old woman to converse using a computer-generated voice.
Lucy TassellHOST
3:33
The implant works by reading brain signals, which are decoded using AI and turned into speech.
Lucy TassellHOST
3:38
The woman is the first patient in a clinical trial involving 10 people with speech and limb paralysis.
Adam FraserHOST
0:16
Hello, everybody, and welcome to the show.
Adam FraserHOST
0:18
I'm your host, Adam Fraser, and today I'm delighted to be joined by Matt Angle, founder and CEO of Paradromics.
Adam FraserHOST
0:26
Matt's a Stanford trade neuroscientist.
Adam FraserHOST
0:28
He founded Paradromics in 2015 with one ambitious goal, a high bandwidth BCI that could restore communication to people who lost it.
Adam FraserHOST
0:37
We're going to dig into his commercial journey and unpack the BCI sector.
Adam FraserHOST
0:42
Matt, a very big welcome to the show.
Adam FraserHOST
1:07
to talk to one of the longest standing members of the BCI community, a true insider, and hear all about your journey, Paradromic's story.
Adam FraserHOST
1:15
We'll unpack a bit about the reg and the reimbursement, the capital side, and then we'll wrap up just by talking about the neurotech sector at large.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.